---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-049835"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:20:48.878952+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BD Q4 revenue $5.9B (+8.3%); FY25 adjusted EPS $14.40 (+9.6%); FY26 guidance

## Summary
- Q4 revenue $5,890M, up 8.3% as reported, 3.9% organic; GAAP EPS $1.72, adjusted EPS $3.96.
- FY25 revenue $21.8B (+8.2% as reported); GAAP EPS $5.82 (-0.7%), adjusted EPS $14.40 (+9.6%).
- FY25 adjusted operating margin up 80 bps to 25.0%; adjusted gross margin up 140 bps.
- Returned $2.2B to shareholders in FY25 via dividends and share repurchases.
- Biosciences/Diagnostic Solutions combination with Waters Corp on track to close near end of Q1 CY2026.

## SEC filing metadata
- accession: 0001628280-25-049835
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000162828025049835/0001628280-25-049835-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000162828025049835/bdx-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-049835
- JSON: https://secwatch.observer/filing/0001628280-25-049835.json
- Plain text: https://secwatch.observer/filing/0001628280-25-049835.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.